Imeglimon (Imeglimin Hydrochloride) 1000 mg is a first-in-class oral antidiabetic medication used to treat Type 2 Diabetes Mellitus. It belongs to a new class of drugs called glimins and is unique because it targets three key defects of the disease simultaneously by improving mitochondrial function.